Women’s health startups continue to attract far less venture capital than the scale of the opportunity warrants. While the industry is expected to grow 17% annually through 2030, a June 2025 report revealed only about 6% of healthcare VC went to femtech the previous year. Systemic underinvestment persists across fertility, menopause, chronic disease, and diagnostics, leaving major unmet health needs unaddressed. This gap highlights both the urgency for innovation and the high growth potential for startups bridging the divide.